Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Combining chemotherapy with dexamethasone may be an effective
treatment for multiple myeloma.
PURPOSE: Phase II trial to study the effectiveness of combining isotretinoin and
dexamethasone in treating patients who have multiple myeloma.